CRISPR/Cas9 technology knocked-in a glutamate to alanine change at position 381 (E381A). This mutation produces a glutamylation-defective mutant. (J:259707)
查看原文 参与反馈
CRISPR/Cas9 technology knocked-in a glutamate to alanine change at position 381 (E381A). This mutation produces a glutamylation-defective mutant. (J:259707)